We have shown that MED1, STARD3, TOP2A, GRB7, THRA, RARA, IGFBP4, CCR7, KRT19, KRT20 and GAS amplification occurred only in HER2-amplified breast cancers with variable frequencies. This evidence concerns the gene MED1 and breast cancer.